The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study
Abstract Immune checkpoint inhibitors (ICIs) are increasingly used in cancer therapy and have been linked to adverse dermatologic effects, including bullous pemphigoid (BP), which may necessitate treatment interruption. This study aims to characterize the immunologic profile of ICI-induced BP (BPICI...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Springer
2025-11-01
|
| سلاسل: | Cancer Immunology, Immunotherapy |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/s00262-025-04172-3 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|